2017～2019年某院7383例不孕症妇女TORCH感染情况分析

Abstract
Figure/Table
References (23)
Related Citation (15)

Download: PDF (0 KB) HTML (35 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the prevalence of TORCH infection in infertile women.Methods Serum samples of 7383 infertile women from January 2017 to December 2019 were collected in the Women and Children′s Hospital Affiliated to Xiamen University, and the TORCH-IgM antibody was detected by chemiluminescence method.Results The positive rate of TORCH-IgM in infertile women was 12.66%.The positive rates of herpes simplex virus IgM,rubella virus IgM, cytomegalovirus IgM and Toxoplasma gondii IgM were 10.89%, 1.22%, 0.39% and 0.16%, respectively.The positive rate of herpes simplex virus IgM was higher than that of rubella virus, cytomegalovirus and Toxoplasma gondii, and the positive rate of herpes simplex virus IgM in 2019 was higher than that of 2017 and 2018, the differences were statistically significant (P＜0.05).The positive rate of TORCH-IgM in different seasons was statistically significant (P＜0.05).There was no significant difference in the positive rate of TORCH-IgM among different age groups(P＞0.05).Conclusion There is a certain percentage of TORCH infection among infertile women.It is necessary to strengthen the screening and monitoring of TORCH infection in such population, so as to achieve prevention and early intervention and improve the quality of newborn population.

Key words： Infertility TORCH infection Serological screening Positive rate

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WEN Gui-Ping
	GE Yun-Sheng
	ZHOU Yu-lin▲

Cite this article:

WEN Gui-Ping,GE Yun-Sheng,ZHOU Yu-lin▲. Analysis of 7383 infertile women infected with TORCH in a hospital from 2017 to 2019[J]. 中国当代医药, 2021, 28(8): 178-181.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I8/178

[1]	高峻，高尔生.中国育龄妇女不孕率及其影响因素分析[J].中国卫生统计，2005，22（1）：27-29.
[2]	郑晓瑛，邱月.中国不孕症疾病经济负担分析[J].中国公共卫生，2012，28（3）：257-260.
[3]	Heerema-McKenney A.Defense and infection of the human placenta[J].APMIS，2018，126（7）：570-588.
[4]	戴薇，李世云，陈先春.试论TORCH感染与不孕不育的关系[J].求医问药，2012，10（10）：533-534.
[5]	徐钰琪，林飞，韦升开，等.南宁市孕妇及不孕妇女的TORCH感染状况分析[J].中国卫生检验杂志，2016，26（20）：3009-3010.
[7]	朱宇宁，尚世强，陈英虎，等.TORCH 实验室规范化检测与临床应用专家共识[J].中华检验医学杂志，2020，43（5）：553-561.
[8]	杨宁，秦卫兵，钟兴明，等.广东地区10531例不孕症妇女TORCH 检测回顾性分析[J].现代医院，2016，16（9）：1255-1256.
[9]	任杉杉，张雨玲，贾俊龙，等.不孕症妇女TORCH 检测结果的回顾性分析[J].西北国防医学杂志，2017，38（6）：381-383.
[10]	满姗姗，刘义庆，郑大伟，等.山东地区不孕不育人群TORCH感染情况分析[J].中国优生与遗传杂志，2017，25（9）：118-121.
[11]	王文娟，张树琪，张娟玲，等.7184例妇女TORCH 检测结果分析[J].微量元素与健康研究，2018，35（2）：31-33.
[6]	Nahmias AJ，Josey WE，Naib ZM，et al.Perinatal risk associated with maternal genital herpes simplex virus infection[J].Am J Obstet Gynecol，1971，110（6）：825-837.
[12]	赵英珍.TORCH感染对育龄妇女不孕不育的影响[J].中国微生态学杂志，2018，30（6）：703-705.
[13]	崔世超，侯海燕，李幼平，等.不孕症临床指南的系统评价[J].中国循证医学杂志，2013，13（8）：947-954.
[14]	黄翠芳，曾庆洋，王爱兰，等.育龄期妇女TORCH-IgM 抗体筛查结果分析[J].中国医药科学，2020，10（7）：178-181.
[15]	王琪，王楠.孕前妇女TORCH抗体、梅毒螺旋体抗体检测结果的分析[J].中国当代医药，2020，27（16）：197-200.
[16]	宋小燕，陈六生.优生优育检查中TORCH抗体检测的应用价值分析[J].临床合理用药杂志，2020，13（11）：173-174.
[17]	杨宁，钟兴明，秦卫兵，等.广东不孕妇女和捐精人群TORCH感染季节分布回顾性分析[J].中国当代医药，2016，23（24）：96-98.
[18]	杨亚波，李苏琴，杜涛，等.广州地区2642例不孕不育妇女TORCH 检测回顾性分析[J].热带医学杂志，2014，14（11）：1453-1455.
[19]	Berger A，Doerr HW.Preventing vertical virus infections：the role of serologic screening of pregnant women[J].Med Microbiol Immunol，2018，207（5-6）：249-253.
[20]	Doerr HW，Berger A.Vaccination against infectious diseases：what is promising?[J].Med Microbiol Immunol，2014，203（6）：365-371.
[21]	Knapp JK，Mariano KM，Pastore R，et al.Progress Toward Rubella Elimination-Western Pacific Region，2000-2019[J].MMWR Morb Mortal Wkly Rep，2020，69（24）：744-750.
[22]	World Health Organization Regional Committee for the Western Pacific.Resolution WPR/RC63.R5：elimination of measles and acceleration of rubella control[EB/OL].https：//iris.wpro.who.int/bitstream/handle/10665.1/8025/WPR_RC0 63_Res05_2012_en.pdf.2012.
[23]	World Health Organization Fact Sheet Rubella[EB/OL].http：//www.who.int/en/news-room/fact-sheets/detail/rubella.2017.11.